NeuroPace (NPCE) EBITDA Yield: History & Chart

NeuroPace, Inc.(NPCE)

Medical - Devices · Mountain View, CA

$12.67-0.55 (-4.16%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About NeuroPace, Inc.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Mountain View, CA

220 employees

www.neuropace.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Joel D. Becker

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
NeuroPace, Inc. (NPCE)	$431.97M	N/A	N/A	N/A	N/A
YD Bio Limited Ordinary Shares (YDES)vs ›	$435.61M	N/A	N/A	N/A	N/A
ARS Pharmaceuticals, Inc. (SPRY)vs ›	$426.51M	N/A	N/A	N/A	N/A
DiaMedica Therapeutics Inc. (DMAC)vs ›	$438.07M	N/A	8.61%	13.81%	19.64%
Assembly Biosciences, Inc. (ASMB)vs ›	$439.55M	N/A	N/A	N/A	N/A
NeoGenomics, Inc. (NEO)vs ›	$424.10M	N/A	1.44%	5.28%	7.05%
Tectonic Therapeutic, Inc. (TECX)vs ›	$422.86M	N/A	N/A	N/A	N/A
Tilray Brands, Inc. (TLRY)vs ›	$422.72M	4.37%	3.97%	3.97%	3.97%
Ovid Therapeutics Inc. (OVID)vs ›	$442.34M	N/A	702.73%	702.73%	702.73%
Prothena Corporation plc (PRTA)vs ›	$419.87M	N/A	6.82%	6.82%	6.82%

NAME

MARKET CAP

EBITDA YIELD

TTM

NeuroPace, Inc. (NPCE)

$431.97M

N/A

YD Bio Limited Ordinary Shares (YDES)vs ›

$435.61M

N/A

ARS Pharmaceuticals, Inc. (SPRY)vs ›

$426.51M

N/A

DiaMedica Therapeutics Inc. (DMAC)vs ›

$438.07M

N/A

8.61%

13.81%

19.64%

Assembly Biosciences, Inc. (ASMB)vs ›

$439.55M

N/A

NeoGenomics, Inc. (NEO)vs ›

$424.10M

N/A

1.44%

5.28%

7.05%

Tectonic Therapeutic, Inc. (TECX)vs ›

$422.86M

N/A

Tilray Brands, Inc. (TLRY)vs ›

$422.72M

4.37%

3.97%

Ovid Therapeutics Inc. (OVID)vs ›

$442.34M

N/A

702.73%

Prothena Corporation plc (PRTA)vs ›

$419.87M

N/A

6.82%

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

NPCE EBITDA Yield Metrics

NPCE Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics